Adhering to Endocrine Therapy Is Hard. What Can Be Done?
Poor adherence to adjuvant endocrine therapy remains an issue among patients with breast cancer. What can oncologists and patients do to improve long-term use?
Medscape Medical News
source https://www.medscape.com/viewarticle/996774?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/996774?src=rss
Comments
Post a Comment